Client News

Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod

InflaRx to Report Second Quarter 2026 Results on August 6, 2026

Promatix Biosciences Awarded Innovate UK Biomedical Catalyst Grant to Advance First-in-Class EGFR × EphA2 Cis-Bispecific ADC

NVision Advances Its Quantum Platform With Expansion Into South Korea

Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments

Novogenia AG Invests in State-of-the-Art Healthcare and Manufacturing Technologies at Its New Hallwang Headquarters

Darwin AG becomes Novogenia AG, strengthening its international position

Formycon AG and OneSource Specialty Pharma announce strategic Manufacturing Partnership for Biosimilars

Axxam and HeartBeat.bio partner to advance human-relevant cardiovascular drug discovery and cardiac safety assessment

Abivax Announces Closing of $920 Million Public Offering